Welcome to our dedicated page for CANNABIS SATIVA news (Ticker: CBDS), a resource for investors and traders seeking the latest updates and insights on CANNABIS SATIVA stock.
Cannabis Sativa, Inc. (CBDS) trades on the OTCQB under the symbol CBDS. The company, through its subsidiaries Wild Earth Naturals, White Rabbit, Hi Brands International, PrestoDoctor, and iBudtender, focuses on developing, manufacturing, and selling herbal-based skin care products in the United States and internationally. Their product line includes Go Deep, a healing salve for pain and inflammation, Face Garden, an antioxidant and moisturizing cream, and more. Additionally, Cannabis Sativa engages in researching, developing, and licensing natural cannabis products like formulations, edibles, topicals, and delivery systems.
Cannabis Sativa, Inc. (OTCQB:CBDS) announced that PrestoDoctor will conduct on-site medical cannabis evaluations at the 9th annual Pennsylvania Cannabis Festival, Pocono 420, at Pocono Raceway on April 22-23. COO Rob Tankson emphasized the ease of the medical evaluation process during the event, which integrates proprietary technology for a streamlined experience while ensuring privacy. PrestoDoctor has successfully hosted over 100 similar events. The festival will feature numerous vendors, food trucks, panels, music, and infield camping. PrestoDoctor is recognized as the top online medical marijuana doctor service and operates in multiple states. The company is engaged in telehealth and cannabis-related intellectual property. The press release also includes forward-looking statements and highlights potential risks involved in the cannabis industry.
Cannabis Sativa, Inc. (OTCQB:CBDS) announces the expansion of PrestoDoctor, its leading telemedicine service, to Louisiana, providing patients with access to online medical cannabis cards. With over 100,000 patients served across nine states, PrestoDoctor aims to enhance patient care by connecting them to licensed medical doctors for evaluations. CEO David Tobias anticipates substantial appointment growth and increased revenue from this launch, emphasizing the convenience and safety of their proprietary online service.
Cannabis Sativa (OTCQB:CBDS) announced that PrestoDoctor is now offering online medical cannabis card services in Texas. The COO, Rob Tankson, emphasized the service's accessibility for patients, while CEO David Tobias highlighted the potential for increased patient appointments and revenue. Established in 2015, PrestoDoctor has served over 100,000 patients across eight states and is praised for its patient satisfaction, holding more than 18,000 5-star reviews. The company is committed to providing compassionate care and education through telemedicine.
Cannabis Sativa Inc. (CBDS) announced a Letter of Intent to merge with MJ Harvest, Inc. (MJHI). This merger will transition CBDS's operations from telehealth to a vertically integrated cannabis business, consolidating operations in seven states. MJHI, which operates extraction and manufacturing facilities, holds significant cannabis licenses and brand partnerships. The merger terms include MJHI shareholders receiving 2.7 shares of CBDS for each MJHI share. Following the merger, MJHI will cease to exist, with CBDS becoming the surviving entity.
Cannabis Sativa, Inc. (CBDS) announced that PrestoDoctor will conduct on-site medical evaluations at the 8th Annual Pennsylvania Cannabis Festival on April 23-24, 2022. This event will take place at Renninger's Farmers Market in Kutztown, PA, featuring over 250 vendors. COO Rob Tankson emphasized the ease of obtaining medical cannabis recommendations during the festival, leveraging proprietary technology to streamline the process. PrestoDoctor has conducted over 100 similar events, maintaining high customer satisfaction ratings. CBDS focuses on telehealth, cannabis-related IP, and ancillary services.
Cannabis Sativa (OTCQB:CBDS) announced that CBGA, a compound in its patented Equadorian Sativa strain, effectively blocks the entry of COVID-19 into human cells, as reported in the Journal of Natural Products. The study indicates that CBGA must be taken orally for potential prevention and treatment of SARS-CoV-2. CEO David Tobias emphasized the importance of this finding and the ongoing research for effective product delivery protocols.
Cannabis Sativa (OTCQB:CBDS) announced that its Brand Ambassador, Randy Lanier, is featured in Netflix's "Need for Weed", part of the "Bad Sport" docuseries. The episode highlights Lanier's dual career as a race car driver and cannabis importer, detailing his achievements, including the 1984 IMSA Championship and Rookie of the Year at the 1986 Indianapolis 500. Lanier now supports cannabis prisoners via Freedom Grow. CEO David Tobias emphasizes the public’s growing acceptance of cannabis legalization, stating that the docuseries tells a critical story in cannabis history.